DOES SMOKELESS TOBACCO CAUSE HYPERTENSION

被引:59
作者
WESTMAN, EC [1 ]
机构
[1] DUKE UNIV,DIV GEN MED,DURHAM,NC
关键词
D O I
10.1097/00007611-199507000-00004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This article reviews the literature regarding the cardiovascular effects of smokeless tobacco use. Articles were identified using a MEDLINE search of the English-language literature from 1966 to 1992 and a manual search of bibliographies of identified articles. From 875 articles regarding smokeless tobacco, 12 pertinent articles were identified, Smokeless tobacco caused a clinically significant acute elevation of systolic blood pressure, diastolic blood pressure, or pulse in 5 of 6 experimental trials. Smokeless tobacco was weakly associated with chronic hypertension in 4 of 6 cross-sectional studies. Health care practitioners should be aware that smokeless tobacco may elevate blood pressure up to 90 minutes after use. Smokeless tobacco use should be considered a potential cause of sodium retention and poor blood pressure control because of its nicotine, sodium, and licorice content.
引用
收藏
页码:716 / 720
页数:5
相关论文
共 34 条
[1]  
Kaplan N., Lieberman E., Clinical Hypertension, (1986)
[2]  
Use of smokeless tobacco among adults-United States, 1991, MMWR, 42, pp. 263-266, (1993)
[3]  
Glover E.D., Schroeder K.L., Henningfield J.E., Et al., An interpretative review of smokeless tobacco research in the United States: Part I, J Drug Educ, 18, pp. 285-310, (1988)
[4]  
Benowitz N., Jacob P., Yu L., Daily use of smokeless tobacco: Systemic effects, Ann Intern Med, 111, pp. 112-116, (1989)
[5]  
Benowitz N., Jacob P., Intravenous nicotine replacement suppresses nicotine intake from cigarette smoking, J Phaimacol Exp Ther, 254, pp. 1000-1005, (1990)
[6]  
Benowitz N., Pharmacologic aspects of cigarette smoking and nicotine addiction, N Engl J Med, 319, pp. 1318-1330, (1988)
[7]  
Hampson N., Smokeless is not saltless, N Engl J Med, 312, pp. 919-920, (1985)
[8]  
Tarazi R., Dustan H., Frohlick E., Plasma volume and chronic hypertension: Relationship to arterial pressure levels in different hypertensive disease, Arch Intern Med, 125, pp. 835-842, (1970)
[9]  
Dustan H., Tarazi R., Bravo E., Dependence of arterial pressure on intravascular volume in treated hypertensive patients, N Engl J Med, 286, pp. 861-866, (1972)
[10]  
Stewart P., Wallace A., Valentino R., Mineralocorticoid activity of liquorice: 11-beta hydroxysteroid dehydrogenase deficiency comes of age, Lancet, 2, pp. 821-824, (1987)